CHAOSTOCOSMOS

Wednesday, 23 January 2013

Double-blind Ampligen research

Rintatolimod produced objective improvement in ET [exercise tolerance] and a reduction in CFS/ME related concomitant medication usage as well as other secondary outcomes.

Read more

No comments:

Related Posts Plugin for WordPress, Blogger...
^ Top